Maintenance of platelet inhibition during antiplatelet therapy
US8716261B2 · kind B2 · utility
15Cited by
8References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2013 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Jul 30, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.